{
    "eid": "2-s2.0-85056609623",
    "title": "Assessment of diagnostic values among CA-125, RMI, HE4, and ROMA for cancer prediction in women with nonfunctional ovarian cysts",
    "cover-date": "2018-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Obstetrics and Gynecology",
            "@code": "2729",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Shina Oranratanaphan",
        "Sinee Wanishpongpan",
        "Wichai Termrungruanglert",
        "Surang Triratanachat"
    ],
    "citedby-count": 8,
    "ref-count": 19,
    "ref-list": [
        "Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma",
        "Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review",
        "An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma",
        "The CA 125 tumour-associated antigen: A review of the literature",
        "Comparison of a novel multiple marker assay vs the RMI for the prediction of epithelial ovarian cancer in patients with a pelvic mass",
        "HE4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women",
        "The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms",
        "Comprehensive analysis of HE4 expression in normal and malignant human tissues",
        "Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas",
        "A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass",
        "Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management",
        "Evaluation of the diagnostic accuracy of the ROMA in women with pelvic mass",
        "Proportion of ovarian cancer in overall ovarian masses",
        "HE4 a novel tumour marker for ovarian cancer: Comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases",
        "HE4 and CA125 as a diagnostic test in ovarian cancer: Prospective validation of the ROMA",
        "The use of HE4 in the prediction of ovarian cancer in asian women with a pelvic mass",
        "Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age",
        "HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Ratchadapiseksompotch Fund",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}